Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Autoimmune Disorders

Free Subscription 07.09.2026 1 Diabet Med 15 Diabetes Res Clin Pract 4 J Autoimmun 2 J Immunol 1 J Nephrol 1 J Neuroimmunol 2 J Rheumatol 6 Mult Scler 4 N Engl J Med 2 Neurol Genet 1 Neurology 2 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Diabet Med

1. MAJSTOROVIC M, McGorm KJ, Wentworth JM, Sawyer A, et al
   Australian healthcare professionals' perspectives and experiences on screening and monitoring islet autoimmunity: A qualitative exploration.
   Diabet Med. 2026 Sep 1:e70445. doi: 10.1111/dme.70445.
   PubMed         Abstract available
   
   

   
   Diabetes Res Clin Pract

2. SYDNEY GI, Paschou SA
   Immune therapies in type 1 diabetes deserve immune biomarkers.
   Diabetes Res Clin Pract. 2026;239:113435.
   PubMed         Abstract available
   
   
3. LIT VF, Bak JCG, van Bon AC, Serne EH, et al
   On target? Cardiovascular risk factor patterns in type 1 and type 2 diabetes: real-world attainment of cardiovascular risk factor targets and medication prescriptions.
   Diabetes Res Clin Pract. 2026;239:113440.
   PubMed         Abstract available
   
   
4. ALHARBI TH, Alzahrani HA, Alromaihi RA, Alzahrani S, et al
   Immune checkpoint inhibitor-induced type 1 diabetes mellitus: incidence, risk factors, and prognostic implications - a systematic review and meta-analysis.
   Diabetes Res Clin Pract. 2026;239:113439.
   PubMed         Abstract available
   
   
5. RUSSO GT, Da Porto A, Nicolucci A, Ceriello A, et al
   Quality of care and clinical characteristics of adults with type 1 diabetes in Italy: insights from the 2025 AMD Annals initiative.
   Diabetes Res Clin Pract. 2026;239:113446.
   PubMed         Abstract available
   
   
6. DAVIS GM, Forlenza GP, Gehr B, Pemberton J, et al
   Simplifying meal bolusing with Omnipod 5: real-world outcomes to support simplified user-initiated insulin dosing strategies in managing type 1 or type 2 diabetes.
   Diabetes Res Clin Pract. 2026;239:113450.
   PubMed         Abstract available
   
   
7. CYRANKA K, Klupa T, Matejko B, Juryk A, et al
   Exploring key targets for psychodiabetological interventions in adults with type 1 diabetes mellitus: an exploratory network and intervention modeling study using Polish MyDiaMate data.
   Diabetes Res Clin Pract. 2026;239:113455.
   PubMed         Abstract available
   
   
8. PEPRAH OSEI E, Ekpor E, Akyirem S, Olanrewaju F, et al
   Global prevalence and correlates of diabetes distress in type 1 diabetes: A systematic review and meta-analysis.
   Diabetes Res Clin Pract. 2026;239:113452.
   PubMed         Abstract available
   
   
9. ST JACQUES ME, Guevara JL, Agnihotram R, von Oettingen J, et al
   Obesity in pediatric type 1 diabetes: an underestimated health problem.
   Diabetes Res Clin Pract. 2026;239:113459.
   PubMed         Abstract available
   
   
10. LEE D, Pham AQ, Abreu M
    U-500 regular insulin in automated insulin delivery systems for severe insulin resistance: A single-center retrospective cohort.
    Diabetes Res Clin Pract. 2026;239:113460.
    PubMed         Abstract available
    
    
11. YAMAOKA T, Sugiyama T, Kashiwagi K, Furuno T, et al
    Trends of insulin pump therapy and continuous glucose monitoring use among people with type 1 diabetes by institution and region in Japan during 2014 and 2022: an observational study using nationwide claims data.
    Diabetes Res Clin Pract. 2026;239:113462.
    PubMed         Abstract available
    
    
12. BONHOURE A, Yardley JE, Boudreau V, Lepine L, et al
    Physical and psychosocial complications faced by postmenopausal women with type 1 diabetes: a cross-sectional BETTER analysis.
    Diabetes Res Clin Pract. 2026;239:113484.
    PubMed         Abstract available
    
    
13. STANGER C, Nahum-Shani I, Kowatsch T, Lim-Liberty F, et al
    Financial incentives and health coaching to improve glycemic outcomes among young adults with type 1 diabetes: A factorial randomized trial (SweetGoals).
    Diabetes Res Clin Pract. 2026;239:113495.
    PubMed         Abstract available
    
    
14. RATAN P, Abreu M, Saldarriaga L, Faria HS, et al
    Contemporary automated insulin delivery systems in older adults with type 1 diabetes: A systematic review and meta-analysis.
    Diabetes Res Clin Pract. 2026;239:113492.
    PubMed         Abstract available
    
    
15. RUIZ GRACIA T, Nattero-Chavez L, Arranz Martin A, de la Calle de la Villa E, et al
    Technology choice, glycemic control and patient-reported outcome measures in adults with type 1 diabetes: A randomized crossover trial comparing a smart insulin pen with an automated insulin delivery system (EBIACE-1).
    Diabetes Res Clin Pract. 2026;239:113505.
    PubMed         Abstract available
    
    
16. ZHANG C, Yuan T, Chen X, Zheng Y, et al
    Prevalence and types of insulin-pump-related skin complications in children and adolescents with type 1 diabetes: A systematic review and meta-analysis.
    Diabetes Res Clin Pract. 2026;239:113412.
    PubMed         Abstract available
    
    

    
    J Autoimmun

17. KARINO K, Oba S, Imai R, Kono M, et al
    HIF-1alpha regulates ADAM9 expression in Th17 cells during autoimmune disease.
    J Autoimmun. 2026;164:103621.
    PubMed         Abstract available
    
    
18. GANDOLFO S, Parodis I, Mauro D, Riccio F, et al
    Difficult-to-treat systemic lupus erythematosus: from refractory disease to a multidimensional clinical trajectory.
    J Autoimmun. 2026;164:103617.
    PubMed         Abstract available
    
    
19. CHEN Z, Yan S, Deng C, Wang W, et al
    Unveiling the role of abnormal copper metabolism in systemic lupus erythematosus.
    J Autoimmun. 2026;163:103614.
    PubMed         Abstract available
    
    
20. GUO H, Liu W, Xiang W, Zeng L, et al
    PTX3 in rheumatic and autoimmune diseases: Pathogenesis, biomarker potential, and therapeutic implications.
    J Autoimmun. 2026;164:103620.
    PubMed         Abstract available
    
    

    
    J Immunol

21. CORTEZ A, Mendyka LK, Roy A, Skydel JJ, et al
    A skin-kidney neutrophil axis links ultraviolet exposure to renal angiogenesis and tissue remodeling in healthy and lupus kidneys.
    J Immunol. 2026;215:vkag178.
    PubMed         Abstract available
    
    
22. SCHARMANN SD, Faber F, Hoorens van Heyningen L, Reljic M, et al
    Nanobodies specific for Vbeta11 enable detection and noninvasive imaging of antigen-specific T cells in vivo.
    J Immunol. 2026;215:vkag237.
    PubMed         Abstract available
    
    

    
    J Nephrol

23. GUZZO G, Al-Gobari M, Jaques C, Teta D, et al
    Crescents in native kidney biopsies from patients with IgA nephropathy and the risk of recurrence after kidney transplantation: a retrospective cohort study, systematic literature review and meta-analysis of observational studies.
    J Nephrol. 2026 Sep 4:aajag169. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Neuroimmunol

24. JIN J, Chen Z, Zhang Y, Wang X, et al
    Single-cell transcriptomic analysis reveals systemic immune dysregulation and identifies PLEK as a candidate hub gene associated with CD8+ T-cell activation in myasthenia gravis.
    J Neuroimmunol. 2026;421:579077.
    PubMed         Abstract available
    
    

    
    J Rheumatol

25. ALSULAMI RA, Chugani B, Johnstone J, Yeh EA, et al
    Therapeutic Drug Monitoring of Rituximab to Predict Early B-Cell Repopulation in Children With Inflammatory Diseases.
    J Rheumatol. 2026;53:1013-1018.
    PubMed         Abstract available
    
    
26. LOUTHRENOO W, Hoi A, Golder V, Chen YH, et al
    Longitudinal comparison of treat-to-target states and clinical outcomes in patients with late-onset versus early-onset systemic lupus erythematosus.
    J Rheumatol. 2026 Sep 1:jrheum.2026-0047. doi: 10.3899/jrheum.2026-0047.
    PubMed         Abstract available
    
    

    
    Mult Scler

27. LOREFICE L, Fenu G, Fantola G, Zoledziewska M, et al
    Ultra-processed foods and multiple sclerosis: Evidence, pitfalls and perspectives.
    Mult Scler. 2026 Sep 3:13524585261481479. doi: 10.1177/13524585261481479.
    PubMed         Abstract available
    
    
28. HARRISON KL, Levasseur VA, Conway AP, Bhattiprolu K, et al
    Racial disparities in multiple sclerosis quality of care metrics.
    Mult Scler. 2026 Sep 3:13524585261478826. doi: 10.1177/13524585261478826.
    PubMed         Abstract available
    
    
29. KING R, Marrie RA, van der Mei I, Banwell B, et al
    Global prevalence of multiple sclerosis surpasses 3 million: 2024 update of the Multiple Sclerosis International Federation Atlas of MS.
    Mult Scler. 2026 Sep 3:13524585261479954. doi: 10.1177/13524585261479954.
    PubMed         Abstract available
    
    
30. FEYS P, Moghames P, Kasilingam E, King R, et al
    Impact of multiple sclerosis symptoms survey: Patient-reported data on the prevalence, burden, and management of multiple sclerosis symptoms in Europe.
    Mult Scler. 2026 Sep 1:13524585261480514. doi: 10.1177/13524585261480514.
    PubMed         Abstract available
    
    
31. KESWA ML, Desai SR, Dzukou FK, Smith JB, et al
    Cesarean sections prior to 39 weeks among pregnant patients with multiple sclerosis.
    Mult Scler. 2026 Sep 3:13524585261481729. doi: 10.1177/13524585261481729.
    PubMed         Abstract available
    
    
32. MERID MW, Eisner A, Park DJ, Tanner S, et al
    DNA methylation partially mediates the associations of Mediterranean diet scores with MS onset-risk: Results from the Ausimmune case-control study.
    Mult Scler. 2026;32:1022-1037.
    PubMed         Abstract available
    
    

    
    N Engl J Med

33. ZHANG Y, Lv J, Zhang H
    Telitacicept for IgA Nephropathy. Reply.
    N Engl J Med. 2026;395:932-933.
    PubMed        
    
    
34. MUHAMMAD A, Yuan L, Xiao X
    Telitacicept for IgA Nephropathy.
    N Engl J Med. 2026;395:932.
    PubMed        
    
    
35. HUNG MH, Cheng SY
    Telitacicept for IgA Nephropathy.
    N Engl J Med. 2026;395:931-932.
    PubMed        
    
    
36. CHENG YH, Shang K, Qin C, Dong MH, et al
    Lentiviral In Vivo CD19 CAR T-Cell Therapy in Neurologic Autoimmune Disorders.
    N Engl J Med. 2026;395:926-929.
    PubMed        
    
    

    
    Neurol Genet

37. MENIH M, Hojs Fabjan T, Maver A, Peterlin B, et al
    Two Cases of Multiple Sclerosis in a Family With X-Linked Charcot-Marie-Tooth Disease.
    Neurol Genet. 2026;12:e200426.
    PubMed         Abstract available
    
    
38. MENDIS DD, Vallamchetla SK, Marin Collazo IV, Sandhu SJS, et al
    Multiple Sclerosis Misdiagnosis in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy: A Genotype-Misphenotype Study.
    Neurol Genet. 2026;12:e200430.
    PubMed         Abstract available
    
    

    
    Neurology

39. LIAMPAS A, Artemiadis A, Tseriotis VS, Prados F, et al
    Prevalence of Slowly Expanding Lesions in Patients With Multiple Sclerosis: A Systematic Review and Meta-Analysis.
    Neurology. 2026;107:e218474.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

40. DROBEK A, Delacretaz M, Vasilakou A, Monguio-Tortajada M, et al
    The SLC15A4-TASL complex is essential for lupus development in mice.
    Proc Natl Acad Sci U S A. 2026;123:e2618215123.
    PubMed         Abstract available
    
    
41. LUTTEROTTI A, Ludersdorfer T, Docampo MJ, Morax M, et al
    Treatment of multiple sclerosis with peptide-coupled red blood cells induces antigen-specific T regulatory cells.
    Proc Natl Acad Sci U S A. 2026;123:e2614908123.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum